Axxcess Wealth Management LLC Cuts Stock Holdings in Doximity, Inc. $DOCS

Axxcess Wealth Management LLC trimmed its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 7.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,067 shares of the company’s stock after selling 317 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Doximity were worth $249,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Ballentine Partners LLC acquired a new stake in Doximity in the 1st quarter valued at $201,000. Wealth Enhancement Advisory Services LLC grew its stake in Doximity by 196.6% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 13,570 shares of the company’s stock valued at $787,000 after acquiring an additional 8,995 shares during the period. Bank of Nova Scotia acquired a new stake in Doximity in the 1st quarter valued at $651,000. New York State Teachers Retirement System grew its stake in Doximity by 10.9% in the 1st quarter. New York State Teachers Retirement System now owns 113,145 shares of the company’s stock valued at $6,566,000 after acquiring an additional 11,078 shares during the period. Finally, Jump Financial LLC acquired a new stake in Doximity in the 1st quarter valued at $3,125,000. 87.19% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Regina M. Benjamin sold 5,000 shares of the business’s stock in a transaction dated Friday, October 10th. The shares were sold at an average price of $70.84, for a total transaction of $354,200.00. Following the transaction, the director owned 19,839 shares of the company’s stock, valued at approximately $1,405,394.76. The trade was a 20.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $57.09, for a total transaction of $114,180.00. Following the transaction, the director directly owned 16,618 shares in the company, valued at approximately $948,721.62. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 37,000 shares of company stock valued at $2,635,880. 31.30% of the stock is currently owned by insiders.

Doximity Trading Up 0.3%

Shares of DOCS stock opened at $67.56 on Friday. The company’s 50-day moving average price is $69.22 and its 200-day moving average price is $61.28. The stock has a market cap of $12.65 billion, a price-to-earnings ratio of 67.56, a PEG ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a twelve month low of $40.87 and a twelve month high of $85.21.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The business’s quarterly revenue was up 15.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities research analysts predict that Doximity, Inc. will post 0.99 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on DOCS shares. KeyCorp lifted their price target on shares of Doximity from $75.00 to $80.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Robert W. Baird lifted their price target on shares of Doximity from $75.00 to $80.00 and gave the company an “outperform” rating in a research note on Thursday, September 11th. The Goldman Sachs Group set a $64.00 target price on shares of Doximity and gave the stock a “sell” rating in a research note on Wednesday, October 1st. Raymond James Financial set a $75.00 target price on shares of Doximity in a research note on Wednesday, September 10th. Finally, JPMorgan Chase & Co. reaffirmed an “underweight” rating and set a $62.00 target price on shares of Doximity in a research note on Friday, October 10th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Doximity has a consensus rating of “Hold” and an average target price of $69.37.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.